Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries. Read More
The European Medicines Agency (EMA) said it has not received any application from the COVID-19 vaccine Covishield maker Serum Institute of India (SII) for authorisation. ...
The first batch of Sputnik vaccine is expected to be produced at Serum Institute of India (SII)'s facilities in September, said Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund on Tuesday. ...
World Health Organisation (WHO) chief scientist Soumya Swaminathan on Friday said 15 countries in the European Union (EU) now recognise Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford Universi ...
Charge d'affaires of Belgium Embassy Arnaud Lion on Friday said that recognition of Covishield by his country will have a positive impact for everyone getting the vaccine shot in India and abroad. ...
Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday. ...
